< Back to all Breaking News
RLGY, RGLS, OPK...
5/13/2019 13:05pm
Fly Insider: Regulus, Exelixis among week's notable insider transactions
Welcome to "Fly Insider," The Fly's weekly recap of notable insider stock transactions.
NOTABLE INSIDER PURCHASES: Significant insider purchases reported in the prior week from May 6 through May 10 include:
- CEO of Realogy (RLGY) Ryan Schneider purchased 119,300 shares of company stock at $8.38 per share for a total transaction value of $999,734
- Chairman of Regulus Therapeutics (RGLS) Stelios Papadopoulos purchased 370,370 shares of company stock at $1.08 per share for a total transaction value of $400,000
- Chairman of Opko Health (OPK) Phillip Frost purchased 285,000 shares of company stock at $2.06 per share for a total transaction value of $585,789
- Chairman of Ultra Clean Holdings (UCTT) Clarence Granger purchased 44,000 shares of company stock at $14.18 per share for a total transaction value of $623,902
- Chairman of Fluor (FLR) Alan Boeckmann purchased 16,000 shares of company stock at $29.81 per share for a total transaction value of $476,960
- Director of First Financial Bankshares (FFIN) Johnny Trotter purchased 5,000 shares of company stock at $61.29 per share for a total transaction value of $306,450
- Officer of Genuine Parts (GPC) Scott Sonnemaker purchased 5,000 shares of company stock at $99.01 per share for a total transaction value of $495,050
- Director of Alleghany Corp (Y) Lauren Tyler purchased 1,485 shares of company stock at an average price of $668.61 for a total transaction value of $992,885
- Chairman of AG Mortgage Investment Trust (MITT) David Roberts purchased 50,000 shares of company stock at $16.53 per share for a total transaction value of $826,500
- Director of MGM Resorts International (MGM) purchased 800,000 shares of company stock at an average price of $25.40 per share for a total transaction value of $20,322,240
NOTABLE INSIDER SALES: Significant insider sales reported in the prior week from May 6 through May 10 include:
- CFO of TrueBlue (TBI) Derrek Gafford sold 40,000 shares of company stock at $24.16 per share for a total transaction value of $966,432
- CEO of American Homes 4 Rent (AMH) David Singelyn sold 1,040,000 shares of company stock at $23.67 per share for a total transaction value of $24,615,448
- Director of Appfolio (APPF) William Rauth sold 20,000 shares of company stock at $96.11 per share for a total transaction value of $1,922,206
- Director of Exelixis (EXEL) Lance Willsey sold 50,000 shares of company stock at $20.36 per share for a total transaction value of $1,018,000
- VP of Hudson Pacific Properties (HPP) Christopher Barton sold 27,756 shares of company stock at $34.67 per share for a total transaction value of $962,228
- VP of Neenah (NP) Larry Brownlee sold 5,000 shares of company stock at an average price of $62.52 per share for a total transaction value of $312,600
NOTABLE PRICE MOVEMENT AFTER INSIDER TRANSACTIONS: Regulus Therapeutics is up approximately 13% since its chairman purchased 370,370 shares, while Exelixis is down approximately 9% since a director sold 50,000 shares.